High-Dose Duloxetine and CBT for Treatment-Resistant OCD and Depression
Author Information
Author(s): Muacevic Alexander, Adler John R, Bokhari Syed Ali, Nasr Mohamed H, Alawadhi Yasmeen T
Primary Institution: Al Amal Psychiatric Hospital, Emirates Health Services, Dubai, ARE
Hypothesis
Can high-dose duloxetine combined with cognitive-behavioral therapy effectively treat severe treatment-resistant obsessive-compulsive disorder with comorbid depression?
Conclusion
High-dose duloxetine combined with cognitive-behavioral therapy led to significant improvements in a patient with treatment-resistant OCD and depression.
Supporting Evidence
- The patient had severe OCD and depression for over a decade.
- High-dose duloxetine was titrated to 180 mg/day.
- Significant improvements were observed in both depressive and obsessive-compulsive symptoms.
- The patient maintained improvements over six months.
- Combining pharmacotherapy with CBT led to better outcomes.
Takeaway
A man with severe OCD and depression got better after taking a high dose of a medicine called duloxetine and doing therapy. This helped him feel happier and more in control.
Methodology
The patient was treated with high-dose duloxetine and cognitive-behavioral therapy focusing on exposure and response prevention.
Potential Biases
Potential bias due to the subjective nature of self-reported symptom improvement.
Limitations
The findings are based on a single case report, limiting generalizability.
Participant Demographics
42-year-old Middle-Eastern male with a history of treatment-resistant OCD and depression.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website